|93.03|| +1.39 / +1.52%|
Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
|Omar S. Ishrak||Chairman & Chief Executive Officer|
|Mark Ploof||Senior Vice President-Global Operations|
|Karen L. Parkhill||Chief Financial Officer & Executive Vice President|
|Richard E. Kuntz||Chief Scientific, Clinical & Regulatory Officer|
|Geoffrey Straub Martha||Executive VP & President-Restorative Therapies|